(NYSE: AORT) Artivion's forecast annual revenue growth rate of 9.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Artivion's revenue in 2025 is $422,646,000.On average, 9 Wall Street analysts forecast AORT's revenue for 2025 to be $21,151,489,015, with the lowest AORT revenue forecast at $20,195,936,496, and the highest AORT revenue forecast at $21,838,899,380. On average, 9 Wall Street analysts forecast AORT's revenue for 2026 to be $23,457,227,296, with the lowest AORT revenue forecast at $21,960,179,224, and the highest AORT revenue forecast at $24,439,309,782.
In 2027, AORT is forecast to generate $26,232,924,972 in revenue, with the lowest revenue forecast at $24,959,486,612 and the highest revenue forecast at $27,357,606,024.